Diagnostic importance of lung perfusion/ventilation scans in the evaluation of pulmonary embolism in COVID-19 patients: systematic review of the literature.


Journal

Nuclear medicine communications
ISSN: 1473-5628
Titre abrégé: Nucl Med Commun
Pays: England
ID NLM: 8201017

Informations de publication

Date de publication:
01 03 2023
Historique:
pubmed: 3 2 2023
medline: 10 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

To investigate the outcomes of ventilation/perfusion scintigraphy on the diagnosis of pulmonary embolism in coronavirus disease 2019 (COVID-19) patients, we performed a systematic review of the available literature. PubMed and Scopus were systematically searched up to 4 June 2022, for relevant studies. We included studies on patients with COVID-19 who have performed ventilation/perfusion scintigraphy for diagnosis of pulmonary embolism to describe any diagnosis outcome. Irrelevant and non-English articles were excluded. Overall, 27 articles were included in our review. The database search yielded studies from PubMed, Scopus, and studies identified through reviewing the reference list of included studies. Extracted information from the included studies could be categorized into several aspects: Diagnosis of pulmonary embolism with Q single-photon emission computed tomography (SPECT) CT, Tracheobronchial uptake, Diagnostic value of V/Q rather than Q at diagnosis pulmonary embolism, Different characteristics (morphological alterations) of COVID-19 in ventilation orperfusion scan, the prevalence of pulmonary embolism with Q or V/Q criteria, and Design of radiotherapy planning in lung cancer patients with COVID-19. Different perfusion patterns in COVID-19 are challenging but can be alleviated by adding SPECT/computed tomography (CT) to lung perfusion scans. Although perfusion only SPECT/CT can rule out or rule in others in considerable number of patients, ventilation scan is still needed in certain patients.

Identifiants

pubmed: 36728902
doi: 10.1097/MNM.0000000000001655
pii: 00006231-202303000-00002
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-186

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Dong E, Du H, Gardner L. An interactive web-based dashboardto track COVID-19 in real time. Lancet Infect Dis 2020; 20:533–534.
Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thrombos Haemostas: JTH 2020; 18:786–787.
The Lancet H. COVID-19 coagulopathy: an evolving story. The Lancet Haematol 2020; 7:e425.
Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers DA, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191:148145–148150.
Gopalan D, Delcroix M, Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26:160108.
Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol 2007; 80:3–11.
Gropler RJ. Recent advances in metabolic imaging. J Nucl Cardiol 2013; 20:1147–1172.
Saltzman HA, Alavi A, Greenspan RH, Hales CA, Stein PD, Terrin M, et al. Value of the ventilation/perfusion scan in acute pulmonary embolism.Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263:2753–2759.
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54:1901647.
Das JP, Yeh R, Schöder H. Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE. Eur J Nucl Med Mol Imaging 2021; 48:794–799.
Lu Y, Macapinlac HA. Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic. Eur J Nucl Med Mol Imaging 2020; 47:2064–2065.
Schaefer WM, Knollmann D, Meyer PT. V/Q SPECT/CT in the time of COVID-19: changing the order to improve safety without sacrificing accuracy. J Nucl Med: Off Publ Soc Nucl Med 2021; 62:1022–1024.
WHO. WHO; 2022. https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.who.int/docs/default-source/coronaviruse/2022-01-21-global-technical-brief-and-priority-action-on-omicron-sars-cov-2-variant.pdf&ved=2ahUKEwjh--myuJT4AhVSOH0KHc2tA3AQFnoECBAQAQ&usg=AOvVaw1AvfXRQeCCMu4Qk1t5zgdF . [Accessed 15 February 2022]
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62:e1–34.
Acuña Hernandez M, Morales Avellaneda T, Narvaez Gomez JA, Sanchez Orduz L. Findings in [99mTc]MAA SPECT/CT in the diagnosis and follow-up of pulmonary embolism after infection by SARS-CoV-2 (COVID-19). Nucl Med Rev Cent East Eur 2021; 24:120–121.
Bahloul A, Verger A, Mandry D, Jeulin H, Goehringer F, Karcher G, et al. Signs of tracheobronchitis may constitute the principal finding on the lung SPECT/CT images of COVID-19 patients. Eur J Nucl Med Mol Imaging 2021; 48:2525–2530.
Bajc M, Hedeer F, Lindqvist A, Trägårdh E. Assessment of ventilation and perfusion in patients with COVID-19 discloses unique information of pulmonary function to a clinician: case reports of V/P SPECT. Clin Med Insights: Circ Respir Pulm Med 2021; 15:117954842110301.
Bonnefoy P-B, Bahloul A, Denizot B, Barres B, Moreau-Triby C, Girma A, et al. Functional alterations due to COVID-19 lung lesions—lessons from a multicenter V/Q Scan-based registry. Clin Nucl Med 2022; 10:1097.
Borghetti P, Toraci C, Imbrescia J, Volpi G, Lucchini S, Guerini AE, et al. The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy. Ann Nucl Med 2021; 35:1174–1176.
Burger IA, Niemann T, Patriki D, Fontana F, Beer J-H. Lung perfusion [99mTc]-MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast. Eur J Nucl Med Mol Imaging 2020; 47:2209–2210.
Cobes N, Guernou M, Lussato D, Queneau M, Songy B, Bonardel G, et al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. Eur J Nucl Med Mol Imaging 2020; 47:2453–2460.
Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. The Lancet Respir Med 2021; 9:107–116.
Evbuomwan O, Engelbrecht G. Incidental detection of a lung perfusion defect suspicious of pulmonary embolism on labelled white blood cell quality control imaging—case report. Egypt J Radiol Nucl Med 2021; 52:1–4.
Evbuomwan O, Engelbrecht G, Bergman MV, Mokwena S, Ayeni OA. Lung perfusion findings on perfusion SPECT/CT imaging in non-hospitalized de-isolated patients diagnosed with mild COVID-19 infection. Egypt J Radiol Nucl Med 2021; 52:1–2.
Evbuomwan O, Engelbrecht G, Bergman MV, Mokwena S, Ayeni OA. The prevalence of pulmonary embolism in non-hospitalised de-isolated patients diagnosed with mild COVID-19 disease. S Afr Med J 2021; 111:741–746.
Fielding PA, Morley NCD, Bradley KM. Beware COVID-19 on VQ scans (ventilation/perfusion scintigraphy). QJM: Mon J Assoc Phys 2020; 113:892–893.
Goetz C, Fassbender TF, Meyer PT. Lung scintigraphy imaging features in a young patient with COVID-19. Clin Nucl Med 2020; 45:e523E523–e523e524.
Kurkowska S, Piwowarska-Bilska H, Iwanowski J, Birkenfeld B. Lung perfusion SPECT/CT images associated with COVID-19 – a case series. Nucl Med Rev 2021; 24:35–36.
Le Roux PY, Bonnefoy PB, Bahloul A, Denizot B, Barres B, Moreau-Triby C, et al. Lung scintigraphy for pulmonary embolism diagnosis in COVID-19 patients: a multicenter study. J Nucl Med: Off Publ Soc Nucl Med 2021:S147.
Mahaletchumy T, Muhamad M, Mohammad Kazmin NE, Kori N, Periyasamy P. Pulmonary embolism in an asymptomatic COVID-19 patient detected on ventilation/perfusion SPECT/CT. Clin Nucl Med 2021; 46:e360E360–e360e362.
Mingels C, Vollnberg B, Rominger A, Afshar-Oromieh A, Alberts I. Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumonia. Nuklearmedizin 2021; 60:249–251.
Monaco L, Crivellaro C, Cressoni M, Foti G, Landoni C, Messa C, et al. The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism. Eur J Nucl Med Mol Imaging 2021; 48:3020–3021.
Ozturk BC, Atahan E, Gencer A, Harbiyeli DO, Karabul E, Mazican N, et al. Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism. Ann Nucl Med 2021; 35:1117–1125.
Sajal D, Mudalsha R, Tinu L, Ranganath TG, Dibakar S. Lung perfusion scintigraphy early after COVID-19: a single-center retrospective study. J Nucl Med Technol 2021; 49:320–323.
Sciagrà R, Rubino F, Malandrino D, Bernardeschi N, Pignone AM, Berni A. Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism. Eur J Nucl Med Mol Imaging 2020; 47:2211–2213.
Suh M. In the COVID-19 Era, Is It OK to Perform a Perfusion-Only SPECT/CT for the Diagnosis of Pulmonary Embolism? Springer; 2022. pp. 1–4.
Tan TH, Ismail R. Utility of lung perfusion SPECT/CT in detection of pulmonary thromboembolic disease: outcome analysis. Nucl Med Mol Imaging 2022:1–8.
Tipre DN, Cidon M, Moats RA. Imaging pulmonary blood vessels and ventilation-perfusion mismatch in COVID-19. Mol Imaging Biol 2022.
Venegas C, Marriott CJ, Ho T, Son K, Jamil R, Jamal M, et al. Ventilation and perfusion abnormalities following recovery from noncritical COVID-19. Can J Respir Crit Care Sleep Med 2022:1–10.

Auteurs

Elham Rahmanipour (E)

Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad.

Mohammad Ghorbani (M)

Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad.

Ramin Sadeghi (R)

Department of Nuclear Medicine, School of Medicine, Nuclear Medicine Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad.

Nazanin Sadraei (N)

Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Ali Borhani (A)

Russell H. Morgan Department of Radiology and Radiological Sciences, School of Medicine, Johns Hopkins University, Baltimore, USA.

Sammy Mohammadi (S)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran.

Farivash Karamian (F)

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH